Indian GLP-1 Market Shifts Focus: Volume Reduction, Quality & Nutrient Density Priority
Indian GLP-1 users consume less but demand significantly higher quality, nutrition, and sensory satisfaction from food, creating a distinct product innovation pathway for supplement and functional food manufacturers. Label scrutiny and social eating challenges necessitate targeted product development beyond simple calorie reduction.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
New research from IFF, presented at their Eat Smart Asia: The GLP-1 Shift symposium in New Delhi, highlights a fundamental shift in dietary behaviour among GLP-1 users in India. While volume consumption decreases significantly – for instance, from three-four chapatis to one-two – expectations for product quality, nutritional value, and sensory attributes intensify. This behavioural change transcends mere calorie restriction, signalling a demand for nutrient-dense, palatable options tailored for reduced intake scenarios. Harsch Koshti, Regional Marketing Director, IFF Taste for Greater Asia, noted this shift represents a broader re-evaluation of consumers' relationship with food.
Despite nascent adoption, with Novo Nordisk India estimating only 250,000 users among 250 million obese individuals (0.1%), the Indian GLP-1 market is projected for rapid growth, driven by new market entries and accessible semaglutide products. This expansion underscores an urgent need for manufacturers to adapt their product portfolios. IFF's findings from Delhi, Mumbai, and Bengaluru indicate 90% of respondents experienced altered taste/texture perceptions, with 50% favouring softer textures and 69% seeking balanced flavour impact. This necessitates careful ingredient selection and formulation to maintain appeal in smaller portions.
Consumer behaviour extends to heightened scrutiny of product information. The study reveals 74% of GLP-1 users now meticulously read food labels, focusing on protein content, ingredient lists, and 'natural' or 'preservative-free' assertions. This presents a critical opportunity for transparent product messaging and the development of supplements that clearly communicate functional benefits. However, household purchasing habits lag individual dietary changes; 78% of respondents continue to buy cookies and 63% fried snacks for family, indicating that 'GLP-1-friendly' products must also integrate seamlessly into existing family food routines, perhaps through portion-flexible formats.
Hydration also emerges as a key focus, with 74% of users prioritising daily hydration and 69% integrating coconut water into their routine. This opens avenues for functional beverage innovation, including electrolyte-fortified drinks and low-sugar, high-functionality formulations. The commercial imperative for supplement manufacturers is clear: move beyond weight-loss narratives to address specific nutritional gaps, sensory preferences, and social integration challenges inherent to the GLP-1 user experience.
What this means for India
Indian supplement manufacturers and brand owners must pivot product development to target the evolving GLP-1 consumer, focusing on nutrient-dense, compact formats. Reformulation windows are tightening as the market expands, demanding innovation in high-protein, fibre-rich supplements that offer superior taste and texture for reduced portion sizes. Compliance teams should prepare for increased demand for transparent, detailed nutritional labelling to meet the 74% of users scrutinising ingredient lists. Opportunities exist for functional beverages addressing hydration and specific electrolyte needs, potentially securing first-mover advantage in a rapidly growing segment. Manufacturers must balance individual user needs with household purchasing habits, considering larger pack sizes with portion control options to integrate new products into family consumption patterns.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.